BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $32,739,000 | -24.1% | 32,780,000 | -0.2% | 0.01% | -26.7% |
| Q2 2020 | $43,145,000 | -3.7% | 32,836,000 | -22.3% | 0.02% | -21.1% |
| Q1 2020 | $44,804,000 | -2.4% | 42,266,000 | 0.0% | 0.02% | +35.7% |
| Q4 2019 | $45,914,000 | +5.5% | 42,266,000 | 0.0% | 0.01% | +27.3% |
| Q3 2019 | $43,527,000 | -8.2% | 42,266,000 | 0.0% | 0.01% | -8.3% |
| Q2 2019 | $47,391,000 | -0.8% | 42,266,000 | +0.6% | 0.01% | -25.0% |
| Q1 2019 | $47,754,000 | +2.4% | 42,016,000 | +0.2% | 0.02% | -11.1% |
| Q4 2018 | $46,643,000 | -0.1% | 41,926,000 | +7.7% | 0.02% | +20.0% |
| Q3 2018 | $46,696,000 | +8.2% | 38,926,000 | +6.9% | 0.02% | +7.1% |
| Q2 2018 | $43,151,000 | +19.7% | 36,426,000 | +11.2% | 0.01% | +7.7% |
| Q1 2018 | $36,062,000 | -18.2% | 32,746,000 | -12.1% | 0.01% | -18.8% |
| Q4 2017 | $44,110,000 | -1.0% | 37,243,000 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $44,575,000 | +0.6% | 37,243,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $44,296,000 | +0.7% | 37,243,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $43,970,000 | +0.7% | 37,243,000 | 0.0% | 0.01% | -6.7% |
| Q4 2016 | $43,644,000 | -6.0% | 37,243,000 | 0.0% | 0.02% | -6.2% |
| Q3 2016 | $46,438,000 | +9.1% | 37,243,000 | +1.2% | 0.02% | 0.0% |
| Q2 2016 | $42,559,000 | -1.5% | 36,808,000 | +1.0% | 0.02% | -11.1% |
| Q1 2016 | $43,208,000 | -10.7% | 36,443,000 | +0.6% | 0.02% | -5.3% |
| Q4 2015 | $48,387,000 | -21.8% | 36,211,000 | -21.3% | 0.02% | -26.9% |
| Q3 2015 | $61,841,000 | -15.3% | 46,021,000 | +0.4% | 0.03% | -10.3% |
| Q2 2015 | $73,008,000 | +7.1% | 45,845,000 | +1.9% | 0.03% | +11.5% |
| Q1 2015 | $68,162,000 | +24.0% | 45,010,000 | +0.3% | 0.03% | +23.8% |
| Q4 2014 | $54,975,000 | +13.6% | 44,855,000 | +1.5% | 0.02% | +10.5% |
| Q3 2014 | $48,401,000 | +455.1% | 44,202,000 | +433.8% | 0.02% | +533.3% |
| Q2 2014 | $8,720,000 | -5.1% | 8,280,000 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $9,191,000 | +3.8% | 8,280,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $8,854,000 | – | 8,280,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |